 | Vol. 11.24 – 20 June, 2023 |
| |
|
|
| Scientists leveraged a neoadjuvant anti-PD-1 trial in patients with hepatocellular carcinoma, as well as additional samples collected from patients treated off-label, to explore correlates of response to immune checkpoint blockade within T cell-rich tumors. [Nature Medicine] |
|
|
|
 | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators found that intact cancer cell-intrinsic expression of CD58 and ligation to CD2 was required for anti-tumor immunity and was predictive of treatment response. [Cancer Cell] |
|
|
|
| Researchers elucidated the crystal structure of Sialic acid-binding Ig-like lectin 15 (Siglec-15) and its binding epitope via co-crystallization with an anti-Siglec-15 blocking antibody. [Nature Communications] |
|
|
|
| Human innate immune macrophages were verified as essential to biomaterial rejection in the humanized mouse model and were capable of cross-talk with mouse fibroblasts for collagen matrix deposition. [Science Advances] |
|
|
|
| The authors investigated the effect of both antimyeloperoxidase and antiproteinase 3 IgG on human monocytes. [Journal of Autoimmunity] |
|
|
|
| Scientists investigated the effect of PFAS, short-chain, long-chain, and a mixture of both, on the in vitro activation of primary human immune cells. [Chemosphere] |
|
|
|
| Researchers generated a stable B7-H3×PD-L1 bispecific antibody in IgG1-VHH format by coupling a humanized IgG1 monoclonal antibody against PD-L1 with a humanized camelus variable domain of the heavy-chain of heavy-chain antibody (VHH) against human B7-H3. [Acta Pharmacologica Sinica] |
|
|
|
| The authors compared B cell subsets in human lungs versus circulating cells by analyzing patient-paired lung and blood samples. [Journal of Immunology] |
|
|
|
| Scientists reported the development of a PDL1 × TIGIT bi-specific antibody GB265, a PDL1 × LAG3 bsAb GB266, and a PDL1 × TIGIT × LAG3 tri-specific antibody GB266T, all with intact Fc function. [Scientific Reports] |
|
|
|
|
| Investigators summarize the current understanding of T cell development, CD4+ and CD8+ T cell classification, and differentiation in physiological settings. [Signal Transduction and Targeted Therapy] |
|
|
|
| Scientists discuss the different types of senescent cells present in the tumor microenvironment (TME) and how these senescent cells and their senescence-associated secretory phenotype reshape the TME, affect immune responses, and influence cancer progression. [Developmental Cell] |
|
|
|
|
| Immutep Limited, a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, announced the grant of a new patent by the US Patent Office. [Immutep Limited] |
|
|
|
| A Group Leader in the Monash Biomedicine Discovery Institute, Dr. Mifsud has been awarded funding of $130,000 from the Lungitude Foundation for research into immune system function in transplants. [Monash University] |
|
|
|
| Two University of California San Francisco (UCSF) scientists have received Pew awards in the biomedical sciences for their work in immunology as part of a program that supports promising early-career investigators. [The University of California San Francisco] |
|
|
|
|
| August 28 – 30, 2023 Santa Fe, New Mexico, United States |
|
|
|
|
|
| VIB Center for Cancer Biology – Leuven, Belgium |
|
|
|
| King’s College London – London, England, United Kingdom |
|
|
|
| Karolinska Institutet – Solna, Sweden |
|
|
|
| University of Pittsburgh – Pittsburgh, Pennsylvania, United States |
|
|
|
| Centre for Oncology and Immunology – Hong Kong, Hong Kong |
|
|
|
|